Trials / Completed
CompletedNCT02318212
Dilapan-S / Dilasoft E-Registry in Induced Abortion
International Observational E-Registry on the Use of Dilapan-S/Dilasoft Osmotic Dilators for Cervical Priming Prior to Induced Abortion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 439 (actual)
- Sponsor
- Medicem International CR s.r.o. · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.
Detailed description
International, multicentre, non-interventional, observational e-registry, post market clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for cervical priming before induced abortion with regard to the number of dilators used, duration of insertion of dilators in situ and unusual complications consequent of their use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dilapan-S | Synthetic osmotic dilators Dilapan-S or Dilasoft for cervical priming prior to induced abortion |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-12-17
- Last updated
- 2017-05-19
Source: ClinicalTrials.gov record NCT02318212. Inclusion in this directory is not an endorsement.